Evidence map›Paper›PMID 24098115›Full record

ArticlePLoS pathogens2013

APOBEC3G polymorphism as a selective barrier to cross-species transmission and emergence of pathogenic SIV and AIDS in a primate host.

Annabel Krupp, Kevin R McCarthy, Marcel Ooms, Michael Letko, Jennifer S Morgan, Viviana Simon, Welkin E Johnson

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
3.1field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Adaptation of SIVmac to baboon primary cells results in complete absence ofFrontiers in cellular and infection microbiology · 2024
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Article
  11. Bat-borne virus diversity, spillover and emergence.Nature reviews. Microbiology · 2020
    Review
  12. Article
  13. Article
  14. Transcriptome of the Southern MuriquiFrontiers in genetics · 2020
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

Annabel KruppInstitut für Klinische und Molekulare Virologie, Friedrich-Alexander-University Erlangen-Nuremberg, Erlangen and Nuremberg, Germany ; Department of Biology, Boston College, Chestnut Hill, Massachusetts, United States of America.
Kevin R McCarthy
Marcel Ooms
Michael Letko
Jennifer S Morgan
Viviana Simon
Welkin E Johnson
Icahn School of Medicine at Mount Sinai · USBoston College · USFriedrich-Alexander-Universität Erlangen-Nürnberg · DEHarvard University · US

Funding

Cross-Species transmission and adaptation of primate lentivirusesR01AI083118 · NIAID · HARVARD MEDICAL SCHOOL · PI JOHNSON, WELKIN E · 2009 to 2019
$4.0M
HIV Evolution Driven by Intracellular DefensesR01AI064001 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI SIMON, VIVIANA A · 2005 to 2015
$3.8M
Intrinsic Immunity and AIDSR01AI095092 · NIAID · HARVARD MEDICAL SCHOOL · PI JOHNSON, WELKIN E · 2011 to 2015
$3.0M
Genomic Determinants of Intrinsic Antiviral Host DefensesR01AI089246 · NIAID · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI SIMON, VIVIANA A · 2010 to 2014
$2.1M
NIAID NIH HHS AI064001NIAID NIH HHS AI083118NIAID NIH HHS AI089246NIAID NIH HHS AI095092NIAID NIH HHS R01 AI064001NIAID NIH HHS R01 AI083118NIAID NIH HHS R01 AI089246NIAID NIH HHS R01 AI095092PHS HHS T32 A107647
6 · The paper itself

Abstract

Cellular restriction factors, which render cells intrinsically resistant to viruses, potentially impose genetic barriers to cross-species transmission and emergence of viral pathogens in nature. One such factor is APOBEC3G. To overcome APOBEC3G-mediated restriction, many lentiviruses encode Vif, a protein that targets APOBEC3G for degradation. As with many restriction factor genes, primate APOBEC3G displays strong signatures of positive selection. This is interpreted as evidence that the primate APOBEC3G locus reflects a long-term evolutionary "arms-race" between retroviruses and their primate hosts. Here, we provide direct evidence that APOBEC3G has functioned as a barrier to cross-species transmission, selecting for viral resistance during emergence of the AIDS-causing pathogen SIVmac in captive colonies of Asian macaques in the 1970s. Specifically, we found that rhesus macaques have multiple, functionally distinct APOBEC3G alleles, and that emergence of SIVmac and simian AIDS required adaptation of the virus to evade APOBEC3G-mediated restriction. Our evidence includes the first comparative analysis of APOBEC3G polymorphism and function in both a reservoir and recipient host species (sooty mangabeys and rhesus macaques, respectively), and identification of adaptations unique to Vif proteins of the SIVmac lineage that specifically antagonize rhesus APOBEC3G alleles. By demonstrating that interspecies variation in a known restriction factor selected for viral counter-adaptations in the context of a documented case of cross-species transmission, our results lend strong support to the evolutionary "arms-race" hypothesis. Importantly, our study confirms that APOBEC3G divergence can be a critical determinant of interspecies transmission and emergence of primate lentiviruses, including viruses with the potential to infect and spread in human populations.

Indexed as

Polymorphism, GeneticAcquired Immunodeficiency SyndromeAnimalsAPOBEC-3G DeaminaseCercocebus atysChlorocebus aethiopsCytidine DeaminaseHeLa CellsHumansMacacaSimian Acquired Immunodeficiency SyndromeSpecies SpecificityAPOBEC-3G DeaminaseAPOBEC3G protein, humanCytidine Deaminase

Identifiers

PMID24098115
PMCPMC3789815
OpenAlexW2079979954

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.